Browsing Tag
Alpha Cognition
2 posts
Why Alpha Cognition raised $35m now — And what it means for Alzheimer’s drugs
Alpha Cognition (Nasdaq: ACOG) raises $35M in an oversubscribed public offering to drive Alzheimer’s therapy ZUNVEYL—see how investors are reacting.
Alpha Cognition advances Alzheimer’s treatment with new patent filing
Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF), a pioneering biopharmaceutical company in the development of novel treatments for…